Skip to main content
Equibles
ABPO logo

ABPO · Abpro Holdings, Inc. · Metrics

Track ABPO — free

Use ABPO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABPO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.40 +0.04 (+12.59%) At close · Oct 21
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Accordingly, based on the considerations discussed above, management has concluded there is substantial doubt as to the Company's ability to continue as a going concern within one year after the date these unaudited condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$2.36M
Shares
5.90M
Volume · Oct 21 20.08K Avg daily vol (3M) 11.27K

ABPO metrics

53 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.40
Market cap
$2.36M

Price action

20 metrics
Price change (1W)
+12.7%
Price change (30D)
+11.3%
Price change (3M)
+95.4%
Price change (6M)
+170.6%
Price change (YTD)
-90.5%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
201.7%
Annualized volatility (3M)
182.7%
Beta
0.3
RSI (14D)
59.2
Price vs SMA 50
+35.0%
Price vs SMA 200
-30.7%
Avg volume (3M)
11,266
Relative volume
1.8
Average dollar volume
$3,153

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
5.90M

Valuation

12 metrics
P / E (TTM)
0.2
Trailing earnings · reciprocal yield 539.3%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
1,257.4%
P / FCF
—
P / operating cash flow
—
Earnings yield
85.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1,257.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-5,421.3%
Trailing 12 months
Net margin
-3,951.9%
Gross profit (TTM)
—
Operating profit (TTM)
−$5.34M
Net income (TTM)
$2.01M
Trailing 12 months
Diluted EPS (TTM)
$2.16
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.62
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$1.08
Operating cash flow per diluted share (TTM)
$-1.96
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.14
Stock compensation per diluted share (TTM)
$0.34
Book value per share
$-3.23

Growth

11 metrics
Revenue growth YoY
+50.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+207.5%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
38.4%
Debt / equity
—
Current ratio
0.6
EBITDA (TTM)
−$5.33M
Free cash flow (TTM)
—
Quick ratio
0.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$4.24M
Latest balance sheet
Cash & equivalents
$4.24M
Total assets
$5.24M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6.59M
Capital expenditures (TTM)
—
R&D (TTM)
$373,000
SG&A (TTM)
—
Stock compensation (TTM)
$1.13M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
0
13F filer change QoQ
-4
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.3%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
50 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1893219 CUSIP 000847202 Visit website